803 results on '"Calabresi, Laura"'
Search Results
2. Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production
3. Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
4. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs
5. Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model
6. Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults
7. Apolipoprotein E isoforms differentially affect LCAT-dependent cholesterol esterification
8. Plasma HDL pattern, cholesterol efflux and cholesterol loading capacity of serum in carriers of a novel missense variant (Gly176Trp) of endothelial lipase
9. Emerging therapies for LCAT deficiency: a role for plasma exchange
10. Intracoronary monocyte expression pattern and HDL subfractions after non-ST elevation myocardial infarction
11. Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells
12. Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs
13. CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency
14. Exploiting routine laboratory test to identify primary severe hypertriglyceridaemic patients in a large Italian hospital.
15. LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters
16. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
17. Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
18. Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes
19. Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
20. Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature
21. Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels
22. The MPL mutation
23. A proteomic approach to identify novel disease biomarkers in LCAT deficiency
24. In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3.
25. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
26. Flipped C-Terminal Ends of apoA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs
27. Cholesterol esterification is hampered and cholesteryl esters composition is altered in Alzheimer’s disease
28. Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes
29. Evaluation of high‐density lipoprotein‐bound long non‐coding RNAs in subjects with familial hypercholesterolaemia
30. Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency
31. Familial LCAT deficiency and cardiovascular disease: the game is not over. A case of dramatic multivessel atherosclerosis
32. ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading
33. Effects of a lupin protein concentrate on lipids, blood pressure and insulin resistance in moderately dyslipidaemic patients: A randomised controlled trial
34. Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation
35. Evaluation of high‐density lipoprotein‐bound long non‐coding RNAs in subjects with familial hypercholesterolaemia.
36. Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020
37. Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients
38. Effects of Established Hypolipidemic Drugs on HDL Concentration, Subclass Distribution, and Function
39. Structure of HDL: Particle Subclasses and Molecular Components
40. Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial
41. HDL particles and infection related death: when size matters
42. Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis
43. Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque : Individual Participant Data Meta-Analysis of 20 Prospective Studies
44. Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque:Individual Participant Data Meta-Analysis of 20 Prospective Studies
45. Lupin protein exerts cholesterol-lowering effects targeting PCSK9: From clinical evidences to elucidation of the in vitro molecular mechanism using HepG2 cells
46. Recombinant LCAT (Lecithin: Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome
47. Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants
48. Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms.
49. A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla)
50. Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.